Celldex Therapeutics, Inc. (CLDX)
NASDAQ·Healthcare·Biotechnology
$33.45
-0.62%
Mkt Cap $2.28B
Analyst Ratings
Buy
2
Hold
1
Sell
2
Price Target (9 analysts)
$24.00
Range $24.00 – $24.00
Implied Upside
-28.3%
Consensus $24.00 vs current $33.45
NASDAQ·Healthcare·Biotechnology
$33.45
-0.62%
Mkt Cap $2.28B
Buy
2
Hold
1
Sell
2
Price Target (9 analysts)
$24.00
Range $24.00 – $24.00
-28.3%
Consensus $24.00 vs current $33.45